On December 11, the United States Patent and Trademark Office granted Atai Life Sciences N.V. a new patent for EMP-01, an ...

Recently, researchers from McMaster University reviewed past studies to see if psilocybin (the active chemical in magic ...

A new clinical trial underway in the Lowcountry is drawing attention for its unconventional — and potentially groundbreaking ...

A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more comfortable is ...

The 6,500-square-foot suite offers treatment for obsessive-compulsive and anxiety-related disorders for individuals and ...

With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s chances at ...

Fasedienol is a first-in-class pherine nasal spray that is designed to modulate the olfactory-limbic amygdala fear and anxiety neurocircuits.

She and her family weren’t planning to stay, but between her pessimism about receiving grant funding and her anxiety about ...

In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for obsessive-compulsive disorder than cannabinoids.

In men over 40, erectile dysfunction is usually caused by narrowing of the arteries that bring blood to the penis. But in men ...

Since the 1980s, psychiatry has been dominated by what we might call a ‘disease‑entity’ model of mental health problems. In ...

Researchers have also demonstrated that bodily signals such as breathing patterns and gut rhythms can influence emotional ...